AI Article Synopsis

  • - The study investigates the relationship between CD44 and CD63 protein expressions and various clinicopathological features in breast cancer, including tumor-infiltrating lymphocytes, specific genetic mutations, and patient survival rates.
  • - Findings from 101 breast cancer samples reveal that high CD44 expression is linked to younger age, a triple-negative cancer type, and shorter survival, while high CD63 density correlates with estrogen receptor positivity and lower tumor-infiltrating lymphocyte levels.
  • - The results suggest that CD44 is associated with more aggressive cancer characteristics, while lower CD63 density is observed in tumors with aggressive traits.

Article Abstract

Background: CD44 is a cell-surface transmembrane glycoprotein that participates in the regulation of many cellular processes, including cell division, adhesion, migration and stem-like characteristics. CD63 is involved in the exocytosis process.

Objective: To evaluate the relationship between CD44 and CD63 expression and clinicopathological features, including tumor-infiltrating lymphocytes (TILs), phosphoinositide 3-kinase (PIK3CA) mutation and survival.

Methodology: CD44 and CD63 were stained in samples from 101 breast cancer cases from Peruvian women.

Results: Median age was 52 years, most were most were grade-3 (68%), estrogen receptor (ER)+ (64%) and stage II-III (92%). Median ki67 was 30%, median stromal TIL was 30% and mutation was found in 49%. Longer survival was associated with earlier stages ( = 0.016), lower ki67 ( = 0.023), ER+ ( = 0.034), luminal phenotype ( = 0.029) and recurrence ( < 0.001). CD44 was classified as high cell density staining in 57% and high intensity in 55%. High CD44 density was associated with younger age ( = 0.043), triple-negative phenotype ( = 0.035) and shorter survival ( = 0.005). High CD44 expression was associated with short survival ( = 0.005). High CD63 cell density was found in 56% of cases and was associated with ER-positive ( = 0.045), low TIL levels ( = 0.007), Luminal-A ( = 0.015) and low CD44 intensity ( = 0.032).

Conclusion: CD44 expression was associated with aggressive features and low CD63 density staining.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11489100PMC
http://dx.doi.org/10.3332/ecancer.2024.1779DOI Listing

Publication Analysis

Top Keywords

cd44 cd63
12
cd44
9
clinicopathological features
8
cd63 expression
8
breast cancer
8
cell density
8
density staining
8
high cd44
8
survival 0005
8
0005 high
8

Similar Publications

Osteoarthritis is a degenerative disease of cartilage, and exosome derived from mesenchymal stem cells (MSCs) are considered promising for treating inflammatory musculoskeletal disorders, although their mechanisms are not fully understood. This study aimed to investigate the effects of exosomes derived from canine bone marrow mesenchymal stem cells (cBMSCs-Exos) on the expression of inflammatory factors and genes related cartilage matrix metabolism in IL-1β-induced canine chondrocytes. Canine BMSCs were isolated and characterized for surface markers and trilineage differentiation.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to explore how oxhorn cupping therapy (OHCT) impacts rheumatoid arthritis by analyzing proteins in the body fluid collected from patients after treatment.
  • Thirty patients underwent OHCT, and researchers isolated and examined exosomes from the fluid to identify changes in protein expression, revealing 300 differentially expressed proteins (DEPs).
  • Key pathways and genes associated with the treatment effects were identified, particularly related to signal transduction, with a notable shift in certain protein levels during and after treatment.
  • Overall, the findings suggest that OHCT may have therapeutic effects on rheumatoid arthritis by altering exosomal proteins and pathways involved in the disease.
View Article and Find Full Text PDF

Exosomes derived from the stem cells of human exfoliated deciduous teeth (SHED) hold promise for tissue regeneration. Apoptotic cells release a variety of extracellular vesicles that affect intercellular communication. This study aimed to investigate the angiogenic effects of SHED-derived exosomes modified via apoptosis induction on human umbilical vein endothelial cells (HUVECs).

View Article and Find Full Text PDF

MSC-microvesicles protect cartilage from degradation in early rheumatoid arthritis via immunoregulation.

J Nanobiotechnology

November 2024

Department of Rheumatology and Immunology, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.

Objective: As research into preclinical rheumatoid arthritis (pre-RA) has advanced, a growing body of evidence suggests that abnormalities in RA-affected joint cartilage precede the onset of arthritis. Thus, early prevention and treatment strategies are imperative. In this study, we aimed to explore the protective effects of mesenchymal stem cell (MSC)-derived microvesicles (MVs) on cartilage degradation in a collagen-induced arthritis (CIA) mouse model.

View Article and Find Full Text PDF
Article Synopsis
  • - The study investigates the relationship between CD44 and CD63 protein expressions and various clinicopathological features in breast cancer, including tumor-infiltrating lymphocytes, specific genetic mutations, and patient survival rates.
  • - Findings from 101 breast cancer samples reveal that high CD44 expression is linked to younger age, a triple-negative cancer type, and shorter survival, while high CD63 density correlates with estrogen receptor positivity and lower tumor-infiltrating lymphocyte levels.
  • - The results suggest that CD44 is associated with more aggressive cancer characteristics, while lower CD63 density is observed in tumors with aggressive traits.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!